
    
      This is a 26 subject Multi Center double-blind randomized, Safety & Efficacy, pediatric
      HIV/AIDS Phase II study, to primarily to evaluate the safety and efficacy of HIV-1 immunogen
      and secondarily to examine changes in CD4+ & CD8+ T cell counts, determine Remune vaccines
      effect of multiple inoculations of HIV-1 immunogen on viral replication in children with
      HIV-1 infection & immunogenicity of Remune. Multi-center, randomized , double-blind,
      placebo-controlled, two arm parallel design study of Remune.
    
  